Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official VSports app下载. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2016 Aug;59(8):516-9.
doi: 10.1111/myc.12500. Epub 2016 Mar 30.

Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?

Helena Pomares  1 , Montserrat Arnan  1 , Isabel Sánchez-Ortega  1 , Anna Sureda  1 , Rafael F Duarte  1
Affiliations

"VSports手机版" Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?

Helena Pomares (V体育ios版) et al. Mycoses. 2016 Aug.

Abstract

The aim of this study is to analyse the risk of invasive fungal infection (IFI) and the need for antifungal prophylaxis in patients with acute myeloid leukaemia and myelodysplastic syndromes (AML/MDS) treated with azacitidine VSports手机版. We retrospectively analysed the incidence of IFI according to EORTC-MSG criteria in 121 consecutive AML/MDS patients receiving 948 azacitidine courses (median 5, range 1-43) between June 2007 and June 2015. Four cases of IFI (two possible, one probable aspergillosis and one proven candidemia) occurred in this series. The incidence rate of proven/probable IFI was 0. 21% per treatment cycle and 1. 6% per patient treated for the whole series, and 0. 73% per treatment cycle and 4. 1% per patient treated in those with severe neutropenia. Two patients died from IFI, leading to an IFI-attributable mortality rate of 1. 65% per patient and 0. 21% per treatment cycle. The numbers needed to treat with prophylaxis to prevent one case of IFI are 238 azacitidine cycles or 30 patients throughout their whole treatment course, and 137 azacitidine cycles or 24 patients among those with severe neutropenia. AML/MDS patients treated with azacitidine, including those with severe prolonged neutropenia, have a very low risk of IFI which does not justify the use of antifungal prophylaxis. .

Keywords: Azacitidine; acute myeloid leukaemia; antifungal prophylaxis; invasive fungal infections; myelodysplastic syndromes. V体育安卓版.

PubMed Disclaimer

V体育平台登录 - MeSH terms